Not just. While equally target GLP-1 receptors, Tirz also activates GIP receptors, rendering it a dual agonist. This broader mechanism is considered to improve its consequences on insulin sensitivity and appetite signaling in study types. El reto farmacológico de esta clase de moléculas es el equilibrium entre las tres actividades: https://peptisell.com/product/tirzepatide-pen